vimarsana.com

Page 78 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bharat Biotech s Covaxin shows 81% efficacy after second dose in phase 3 trials

91.60% This comes two days after Indian Prime Minister Narendra Modi was administered a dose of Covaxin as he kicked off the largest phase of COVID-19 vaccination in India. Covaxin is one of two coronavirus vaccines approved by the India drug regulator. The drug had earlier received clearance for emergency use. Advertisement Bharat Biotech conducted a study on 25,800 participants who received a vaccine or placebo in a 1:1 ratio. The results showed that the vaccine candidate was well tolerated. It conducted the trials in partnership with India’s medical research organisation, ICMR. Earlier, the Indian drug regulator s approval triggered a row of criticism from experts pointing to a lack of efficacy data at that time.

NRN Murthy & Sudha Murty get Covishield jab; Uday Kotak says 1st shot was smooth ; Biocon boss calls vaccine a booster dose

India took a step forward in its fight against the Covid-19 pandemic on Monday as it began the process of administering the vaccine to citizens. With some help from the Hyderabad-based Bharat Biotech s Covaxin - developed with the help of the Indian Council of Medical Research and National Institute of Virology - and Covishield which was jointly processed by the Oxford University, British-Swedish company AstraZeneca, and manufactured by Serum Institute of India (SII) in Pune, the country found hope as pictures of people taking the shots surfaced. The inoculation drive entered its second phase on Monday in which the coverage was expanded to include everyone above 60 and those over 45 with co-morbidities.

Latest News Highlights: COVID-19 Vaccination Begins For People Above 60

Latest News Highlights: The government hopes to vaccinate 30 crore people by August in second phase. New Delhi: India today expanded the nationwide vaccination against the coronavirus, opening registerations for people above 60 years and those aged 45 in the second phase of the inoculation drive which began on January 16. Citizens will be able to register and book an appointment for vaccination, anytime and anywhere, using the Co-WIN 2.0 portal or through other IT applications such as Arogya Setu. With 15,510 fresh cases, India s COVID-19 tally has climbed to 1,11,12,241, while the number of recoveries has surged to 1,07,86,457, the Union health ministry said on Monday. The death count due to the viral disease has gone up to 1,57,157 in the country with 106 more fatalities reported in a 24-hour period, the ministry s data updated at 8 am showed.

Andhra Pradesh Governor Biswa Bhusan Harichandan takes COVID Vaccine Shot

AP Guv couple take Coronavirus vaccination shots. Amaravati: March 2: Andhra Pradesh Governor Biswa Bhusan Harichandan and his wife Suprava Harichandan received coronavirus vaccine shots on Tuesday in the third phase of vaccination. They received the first doses of the vaccine at the new government hospital in Gunadala, Vijayawada. Harichandan said he did not feel any inconvenience in getting inoculated and advised all eligible people to come forward and take the vaccine as it helped in curtailing the spread of the virus. The Governor and his wife were administered Covaxin, manufactured by Hyderabad-based Bharat Biotech pharma major. “Indian scientists have demonstrated to the world the country’s capability in the field of vaccine research and development,” he said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.